Imatinib Completed Phase 2 Trials for Chordomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00150072Efficacy and Safety of Imatinib in Chordoma